Chadi Nabhan, MD, of Caris Life Sciences, summarizes the Caris Precision Oncology Alliance and some of the abstracts the alliance presented at ASCO 2023.
The Precision Oncology Alliance includes partnerships with 83 cancer centers and academic institutions. In partnership, Caris Life Sciences provides molecular profiling and artificial intelligence to advance precision medicine. At the recent ASCO conference held in Chicago, the alliance demonstrated a high level of activity.
Dr. Nabhan noted that ASCO 2023 featured numerous abstracts presenting 42 studies involving over 30 cancer types. The findings of these studies show how comprehensive molecular profiling to identify molecular changes can affect tumor behavior and patient outcomes.
To stay up to date on the latest cancer studies, visit checkrare.com/diseases/cancers/
